SFRP2 and neoplasm: By subtracting the ‘free-flowing’ TIC from the tumor TIC, we established ‘free-flowing-corrected’ TICs (ffc-TICs) for SFRP2 and ffc-TICs for IgY-targeted contrast (Fig 3A, 3B and 3E).